Abstract
Leishmaniasis is a prevalent disease in tropical and subtropical regions, affecting almost 90 million people worldwide. The absence of vaccines and chemotherapeutic treatments, which associate efficacy and low toxicity maintain the burden of the disease and allow about 2 million new cases each year. Rational search for targets and lead development to allow better chemotherapy includes und…